vs
Side-by-side financial comparison of NORTHPOINTE BANCSHARES INC (NPB) and Prenetics Global Ltd (PRE). Click either name above to swap in a different company.
Prenetics Global Ltd is the larger business by last-quarter revenue ($92.0M vs $63.4M, roughly 1.5× NORTHPOINTE BANCSHARES INC).
Northpointe Bancshares Inc is a U.S.-based bank holding company operating through its wholly-owned banking subsidiary. It provides a full suite of retail and commercial banking solutions, including deposit accounts, mortgage loans, small business lending, and wealth management services, primarily serving local and regional community markets across the United States.
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
NPB vs PRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $63.4M | $92.0M |
| Net Profit | $22.2M | — |
| Gross Margin | — | 39.2% |
| Operating Margin | — | — |
| Net Margin | 34.9% | — |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.62 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $63.4M | — | ||
| Q4 25 | $43.5M | — | ||
| Q3 25 | $40.3M | — | ||
| Q2 25 | $36.5M | — | ||
| Q1 25 | $30.4M | — | ||
| Q1 23 | — | $92.0M | ||
| Q3 22 | — | $74.7M | ||
| Q1 22 | — | $57.5M |
| Q1 26 | $22.2M | — | ||
| Q4 25 | $23.6M | — | ||
| Q3 25 | $22.2M | — | ||
| Q2 25 | $20.3M | — | ||
| Q1 25 | $17.2M | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q1 23 | — | 39.2% | ||
| Q3 22 | — | 34.5% | ||
| Q1 22 | — | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | 73.5% | — | ||
| Q3 25 | 72.3% | — | ||
| Q2 25 | 73.0% | — | ||
| Q1 25 | 74.4% | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | -7.2% | ||
| Q1 22 | — | — |
| Q1 26 | 34.9% | — | ||
| Q4 25 | 54.4% | — | ||
| Q3 25 | 55.0% | — | ||
| Q2 25 | 55.7% | — | ||
| Q1 25 | 56.8% | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q1 26 | $0.62 | — | ||
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.57 | — | ||
| Q2 25 | $0.51 | — | ||
| Q1 25 | $0.49 | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $487.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $590.0M | — |
| Total Assets | $7.4B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $487.6M | — | ||
| Q4 25 | $496.5M | — | ||
| Q3 25 | $419.2M | — | ||
| Q2 25 | $415.7M | — | ||
| Q1 25 | $321.5M | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q1 26 | $590.0M | — | ||
| Q4 25 | $569.0M | — | ||
| Q3 25 | $623.5M | — | ||
| Q2 25 | $604.3M | — | ||
| Q1 25 | $586.5M | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q1 26 | $7.4B | — | ||
| Q4 25 | $7.0B | — | ||
| Q3 25 | $6.8B | — | ||
| Q2 25 | $6.4B | — | ||
| Q1 25 | $5.9B | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NPB
| Net Interest Income | $41.3M | 65% |
| Noninterest Income | $22.1M | 35% |
PRE
Segment breakdown not available.
